1 Min Read
Nov 15 (Reuters) - GW Pharmaceuticals PLC : * Orphan drug designation granted for epidiolex in dravet syndrome by the FDA * U.S. pediatric epilepsy specialists to treat high need pediatric epilepsy
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.